IMAX names Robert Lister interim principal executive
IMAX Corporation temporarily adjusted its leadership structure while CEO Richard Gelfond is on medical leave.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
IMAX Corporation temporarily adjusted its leadership structure while CEO Richard Gelfond is on medical leave. The board appointed Robert D. Lister, currently Chief Legal Officer and Senior Executive Vice President, to serve as interim principal executive officer until May 1, 2026, when Mr. Gelfond will resume the role.
Mr. Lister will keep his existing responsibilities and will not receive any additional compensation for this interim assignment. The company states there are no special arrangements, related-party transactions, new or amended contracts, or family relationships connected to his appointment, and incorporates his biography by reference from a prior proxy statement.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Interim appointment date: April 16, 2026
Expected end of interim role: May 1, 2026
Report signature date: April 17, 2026
3 metrics
Interim appointment date
April 16, 2026
Board appointed Robert D. Lister as interim principal executive officer
Expected end of interim role
May 1, 2026
Date when Richard Gelfond will resume principal executive officer role
Report signature date
April 17, 2026
Date the 8-K was signed by IMAX officers
Key Terms
principal executive officer, definitive proxy statement, Schedule 14A, Item 404(a) of Regulation S-K, +1 more
5 terms
principal executive officer regulatory
"appointed Robert D. Lister ... to serve as the Company’s interim principal executive officer"
The principal executive officer is the highest-ranking manager who leads a company’s overall strategy, operations and public communication—often acting like the captain of a ship who sets direction and makes final calls. Investors watch this person because their decisions, credibility and ability to deliver results shape company performance, risk and market confidence, and changes in that role can directly affect stock value and corporate accountability.
definitive proxy statement regulatory
"Biographical and other information for Mr. Lister are set forth in the Company’s definitive proxy statement"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Schedule 14A regulatory
"definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
Item 404(a) of Regulation S-K regulatory
"not a party to any arrangement or understanding ... or to any transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K"
emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What leadership change did IMAX (IMAX) disclose in this 8-K?
IMAX temporarily named Chief Legal Officer Robert D. Lister as interim principal executive officer. He will serve in this role during CEO Richard Gelfond’s medical leave and is expected to hold it only until May 1, 2026, alongside his existing responsibilities.
How long will Robert D. Lister serve as interim PEO at IMAX (IMAX)?
Robert D. Lister is expected to serve as interim principal executive officer until May 1, 2026. After that date, the company states that CEO Richard Gelfond will resume the principal executive officer role, returning IMAX’s top leadership structure to its prior arrangement.
Will IMAX (IMAX) pay Robert D. Lister extra compensation as interim PEO?
IMAX reports that Robert D. Lister will not receive any additional compensation for serving as interim principal executive officer. He will continue in his existing roles while temporarily assuming the principal executive responsibilities during CEO Richard Gelfond’s medical leave.
Did IMAX (IMAX) enter any new contracts tied to the interim PEO appointment?
IMAX states it has not entered into, amended, or modified any plan, contract, arrangement, grant, or award in connection with Robert D. Lister’s interim principal executive officer role. The change is presented as a temporary assignment using the company’s existing governance framework.
Where can investors find biographical information on IMAX (IMAX) interim PEO Robert D. Lister?
IMAX refers investors to its definitive proxy statement on Schedule 14A filed with the SEC on April 25, 2025. That document contains biographical and other information about Robert D. Lister, which the company incorporates by reference into this current leadership change disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
